{"id":"https://openalex.org/W2073482926","doi":"https://doi.org/10.1158/1538-7445.am10-2437","title":"Abstract 2437: Engineered human monoclonal antibodies targeting the Mullerian inhibiting substance type II receptor for ovarian cancer therapy","display_name":"Abstract 2437: Engineered human monoclonal antibodies targeting the Mullerian inhibiting substance type II receptor for ovarian cancer therapy","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2073482926","doi":"https://doi.org/10.1158/1538-7445.am10-2437","mag":"2073482926"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am10-2437","doi":"https://doi.org/10.1158/1538-7445.am10-2437","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-2437","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070643615","display_name":"Tatiana A. Karakasheva","orcid":"https://orcid.org/0000-0001-9070-2804","observed_orcids":["https://orcid.org/0000-0001-9070-2804"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatiana A. Karakasheva","raw_affiliation_strings":["1Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044830720","display_name":"Heidi H. Simmons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi H. Simmons","raw_affiliation_strings":["1Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061278758","display_name":"Stephen I. Rudnick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen I. Rudnick","raw_affiliation_strings":["1Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102720068","display_name":"Matthew K. Robinson","orcid":"https://orcid.org/0000-0003-4525-0065","observed_orcids":["https://orcid.org/0000-0003-4525-0065"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew K. Robinson","raw_affiliation_strings":["1Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050269562","display_name":"Gregory Paul Adams","orcid":"https://orcid.org/0000-0003-4207-2881","observed_orcids":["https://orcid.org/0000-0003-4207-2881"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory P. Adams","raw_affiliation_strings":["1Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1289437631"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"8_Supplement","first_page":"2437","last_page":"2437"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4259999990463257,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.7450000047683716},{"id":"https://openalex.org/keywords/scfv-phage-display","display_name":"scFv phage display","score":0.7940000295639038},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.4050000011920929},{"id":"https://openalex.org/keywords/receptor-targeted-therapy","display_name":"receptor-targeted therapy","score":0.43799999356269836},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.49300000071525574},{"id":"https://openalex.org/keywords/fc-fusion-protein","display_name":"Fc fusion protein","score":0.42899999022483826},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.5540000200271606},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7460625171661377},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6010295152664185},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.5958028435707092},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5322378277778625},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5049737095832825},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5012679100036621},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.482783704996109},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4819212257862091},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4787042438983917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32077351212501526},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28604769706726074},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26053568720817566},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07729300856590271}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am10-2437","doi":"https://doi.org/10.1158/1538-7445.am10-2437","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-2437","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2104455255","https://openalex.org/W1973747410","https://openalex.org/W2082596438","https://openalex.org/W2140119811","https://openalex.org/W1639311959","https://openalex.org/W2992697783","https://openalex.org/W2120494074","https://openalex.org/W1918283392","https://openalex.org/W2142385140","https://openalex.org/W2169233831"],"abstract_inverted_index":{"Abstract":[0],"Currently":[1],"available":[2],"approaches":[3],"for":[4,35,57,176,394,411,432],"ovarian":[5,97,144,177,412],"cancer":[6,145,178,413],"therapy":[7],"have":[8],"limited":[9,228],"success":[10],"in":[11,38,47,106,128,147,166,198,322],"the":[12,44,55,83,89,102,123,159,217,238,253,259,284,346,405,424,429],"setting":[13],"of":[14,43,71,95,125,141,164,182,203,205,221,240,256,262,274,286,292,301,348,351,407,423,428],"advanced":[15],"disease.":[16],"Antibody-based":[17],"therapeutics":[18],"offer":[19],"new":[20],"and":[21,61,75,86,108,137,187,307,396],"potentially":[22],"effective":[23],"strategies.":[24,353],"Mu\u0308llerian":[25,45,52],"inhibiting":[26],"substance":[27],"(MIS,":[28],"or":[29,337,365,381],"anti-Mu\u0308llerian":[30],"hormone,":[31],"AMH)":[32],"is":[33,172,390],"known":[34],"its":[36,267,326],"role":[37],"embryonic":[39],"development,":[40],"triggering":[41],"regression":[42],"ducts":[46,53],"mammalian":[48],"males":[49],"(in":[50],"females":[51],"are":[54,313],"source":[56],"uteri,":[58],"Fallopian":[59],"tubes":[60],"upper":[62],"vagina).":[63],"MIS":[64,117],"signals":[65],"via":[66],"a":[67,173,241,249,318,349],"heterodimeric":[68],"receptor,":[69],"consisting":[70],"type":[72,76],"I":[73],"(MISIR)":[74],"II":[77],"(MISIIR)":[78],"receptors,":[79],"where":[80],"MISIIR":[81,100,165,171,195,257,282,302,341],"mediates":[82],"ligand":[84],"specificity":[85],"MISIR":[87],"triggers":[88],"downstream":[90],"signaling":[91,364],"cascade.":[92],"Approximately":[93],"64%":[94],"epithelial":[96],"cancers":[98],"express":[99],"with":[101,158,258,288],"most":[103],"common":[104],"expression":[105,162],"serous":[107],"mucinous":[109],"tumors":[110],"(Bakkum-Gamez":[111],"et.":[112],"al.,":[113,132,151],"Gynecol.":[114],"Oncol.":[115],"2008;108(1):141).":[116],"has":[118,226,297],"been":[119,227],"reported":[120],"to":[121,138,215,230,266,272,324,361,377],"inhibit":[122],"growth":[124],"tumor":[126],"xenografts":[127],"vivo":[129],"(Stephen":[130],"et":[131,150],"Clin.":[133,152],"Cancer":[134,153,433,443],"Res.":[135,154],"2002;8(8):2640)":[136],"trigger":[139],"apoptosis":[140],"primary":[142],"human":[143,209,243,263],"cells":[146,287],"vitro":[148],"(Masaikos":[149],"1999;5(11):3488).":[155],"This,":[156],"along":[157],"highly":[160],"restricted":[161],"pattern":[163],"normal":[167],"tissues,":[168],"suggests":[169],"that":[170,279],"promising":[174],"target":[175,281],"therapy.":[179],"A":[180],"number":[181],"single-chain":[183],"Fv":[184],"molecules":[185,225],"(scFv)":[186],"their":[188,231,359],"bivalent":[189],"derivatives":[190],"(scFv:":[191],"Fc":[192,260],"constructs)":[193],"targeting":[194,300,340],"were":[196],"developed":[197,393],"our":[199],"lab":[200],"by":[201,303],"means":[202],"screening":[204,239,270],"two":[206],"large":[207],"nai\u0308ve":[208],"scFv":[210,224,244,277,294,336,386],"phage":[211,245],"display":[212,246],"libraries.":[213],"However,":[214],"date,":[216],"potential":[218,327],"clinical":[219,328],"utility":[220],"these":[222,293],"anti-MISIIR":[223,385],"due":[229],"low":[232],"binding":[233],"affinity.":[234],"Here,":[235],"we":[236],"describe":[237],"third":[242],"library":[247],"against":[248],"fusion":[250],"protein":[251],"representing":[252],"extracellular":[254],"domain":[255,261],"IgG1":[264],"fused":[265],"C-terminus.":[268],"This":[269],"led":[271],"selection":[273],"six":[275],"unique":[276],"clones":[278],"specifically":[280],"on":[283,358],"surface":[285,308],"varying":[289],"efficiency.":[290],"One":[291],"clones,":[295],"GS45,":[296,387],"demonstrated":[298],"excellent":[299],"flow":[304],"cytometry,":[305],"ELISA":[306],"plasmon":[309],"resonance":[310],"analysis.":[311],"We":[312,400],"currently":[314,391],"cloning":[315],"GS45":[316],"into":[317],"full-length":[319],"IgG":[320],"molecule":[321],"order":[323],"improve":[325],"utility.":[329],"Antibodies":[330],"(or":[331],"antibody-based":[332],"constructs,":[333],"such":[334],"as":[335,345],"scFv:":[338],"Fc)":[339],"could":[342],"be":[343,356,375,404],"used":[344,357],"basis":[347,406],"variety":[350],"therapeutic":[352,409],"They":[354],"can":[355,374,403],"own":[360],"induce":[362],"agonistic":[363],"direct":[366],"antibody-dependent":[367],"cell-mediated":[368],"cytotoxicity":[369],"(ADCC).":[370],"Alternatively,":[371],"MISIIR-targeting":[372],"antibodies":[373],"conjugated":[376],"cytotoxic":[378],"drugs,":[379],"radiolabels":[380],"imaging":[382],"agents.":[383],"The":[384],"described":[388],"here,":[389],"being":[392],"ADCC":[395],"immunodrug":[397],"conjugate":[398],"applications.":[399],"believe":[401],"it":[402],"novel":[408],"strategies":[410],"treatment.":[414],"Citation":[415],"Format:":[416],"{Authors}.":[417],"{Abstract":[418],"title}":[419],"[abstract].":[420],"In:":[421],"Proceedings":[422],"101st":[425],"Annual":[426],"Meeting":[427],"American":[430],"Association":[431],"Research;":[434],"2010":[435],"Apr":[436],"17-21;":[437],"Washington,":[438],"DC.":[439],"Philadelphia":[440],"(PA):":[441],"AACR;":[442],"Res":[444],"2010;70(8":[445],"Suppl):Abstract":[446],"nr":[447],"2437.":[448]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}